Allianz Biotechnologie A EUR/ DE0008481862 /
NAV2024-04-24 | Chg.+2.6300 | Type of yield | Investment Focus | Investment company |
---|---|---|---|---|
197.9500EUR | +1.35% | paying dividend | Equity | Allianz Gl.Investors ▶ |
Funds documents
Date | Document | Year | Language | Filesize |
---|---|---|---|---|
2024-04-25 | Public WebStation Live Factsheet | 2024 | English | - |
2023-12-31 | Account statment | 2023 | German | - |
2023-11-29 | PRIIP Key Information Document | 2023 | English | 300.42 KB |
2023-11-29 | PRIIP Key Information Document | 2023 | German | 264.48 KB |
2023-09-29 | Prospectus | 2023 | German | 560.09 KB |
2023-06-30 | Semi-annual report | 2023 | English | 127.19 KB |
2023-06-30 | Semi-annual report | 2023 | German | 115.13 KB |
2022-12-31 | Account statment | 2022 | English | 185.10 KB |
2022-09-13 | Key Investor Information | 2022 | English | 77.21 KB |
2022-09-13 | Key Investor Information | 2022 | German | 77.64 KB |
2022-07-25 | Prospectus | 2022 | English | 650.16 KB |